Organix Inc., a Massachusetts, USA based corporation, (www.organixinc.com) established in 1986, is a pioneer of Contract Research in Synthetic Organic and Medicinal Chemistry in the United States. Organix is recognized internationally as a premier provider of outstanding services at the discovery end of the drug development pathway. Organix owns and operates a state-of-the-art facility designed expressly for organic chemistry. We hire only Ph.D. level synthetic organic and medicinal chemistry scientists who are capable of handling synthetic projects that range from a single straightforward step to syntheses of highly complex chiral targets that may require 20 synthetic steps. We provide Custom Synthesis of molecules in all structural classes, Design and Synthesis of New Chemical Entities, Structure Activity Relationship Studies, Hit-to-Lead Studies, and Development and Optimization of Synthetic Procedures. Organix is now celebrating our 30th year of providing contract services to a list of over 120 clients that include almost every multinational pharmaceutical company as well as numerous established and emerging biopharmaceutical companies. Visit our website to learn more about us.